- Email: email@example.com
- Phone: +1 609 510 3154
Anton Uvarov has significant experience in the healthcare industry with a particular focus on neuroscience. Anton has started his career in biotechnology investments as equities analyst with Citigroup. He is a co-founding director of several publicly listed companies in Australia including clinical stage companies such as Dimerix, Actinogen Medical and Neuroscientific Biopharmaceuticals. Anton is currently an Executive Director and Chief Scientific Officer of Neuroscientific Biopharmaceuticals, a clinical stage biotechnology company developing new treatments for neurodegenerative diseases and diseases caused by degeneration of the optic nerve. Anton has started his career in biotechnology investments as equities analyst with Citigroup.
Anton holds a Doctor of Philosophy in Biochemistry and Medical Genetics from the University of Manitoba and a Master of Business Administration in Finance from the University of Calgary, Canada.